BioCentury
ARTICLE | Company News

BASF, Verenium deal

November 11, 2013 8:00 AM UTC

Chemicals company BASF completed its tender offer and the acquisition of Verenium for $4 per share in cash in a deal BASF says values Verenium at about $62 million (see BioCentury, Sept. 30). ...